Indirect Particle Agglutination Antibody Testing for Early Diagnosis of Mycoplasma pneumoniae pneumonia in Children.
- Author:
Jin Soo KIM
;
Jeong Hee KO
;
Sung Hee OH
- Publication Type:Original Article
- Keywords:
Mycoplasma pneumoniae;
Pneumonia;
Diagnosis;
Serology;
Children
- MeSH:
Agglutination;
Child;
Disease Outbreaks;
Early Diagnosis;
Humans;
Korea;
Mycoplasma;
Mycoplasma pneumoniae;
Pneumonia;
Pneumonia, Mycoplasma;
Retrospective Studies;
Sensitivity and Specificity
- From:Korean Journal of Pediatric Infectious Diseases
2013;20(2):71-80
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVES: Outbreaks of pneumonia caused by Mycoplasma pneumoniae (MP) occur every 3-4 years in Korea, most recently in 2011. The aim of our study was to determine the optimal time to perform indirect particle agglutination antibody assays to improve early diagnosis of MP pneumonia in children. METHODS: A database of 206 pediatric patients treated for pneumonia at the Hanyang University Hospital from June to October 2011 was analyzed retrospectively for demographic characteristics and laboratory test results. RESULTS: Among the 206 patients treated for pneumonia during the study period, there were 160 children (mean age, 5.44 years) diagnosed with MP pneumonia, who were studied further. The mean age of these MP pneumonia patients was 5.44 years. Antibody titers increased with increasing time between symptom onset and the collection of serum collection: MP titers were <1:640 for sera collected after 5.44 days and titers > or =1:640 for those collected after 8.58 days; P<0.001). Antibody titers were considered positive when they reached > or =1:640. In 42 MP pneumonia patients in whom there was a four-fold or greater increase in titer between successive serum samples, the optimal cut-off time-point for distinguishing between the initial and second titer groups was 7.5 days after the onset of symptoms (sensitivity, 90.5%; specificity, 92.9%). CONCLUSIONS: Negative MP antibody titers earlier than 8 days after the onset of symptoms in children with pneumonia may require repeating to confirm the diagnosis. This finding could optimize diagnosis and result in better therapeutic outcomes of MP pneumonia in children.
